1. Home
  2. IXHL vs ZTEK Comparison

IXHL vs ZTEK Comparison

Compare IXHL & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.98

Market Cap

63.3M

Sector

N/A

ML Signal

HOLD

Logo Zentek Ltd.

ZTEK

Zentek Ltd.

HOLD

Current Price

$0.68

Market Cap

68.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IXHL
ZTEK
Founded
2001
2008
Country
Australia
Canada
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
68.8M
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
IXHL
ZTEK
Price
$3.98
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
384.0K
149.1K
Earning Date
05-15-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.40
52 Week High
$6.39
$1.65

Technical Indicators

Market Signals
Indicator
IXHL
ZTEK
Relative Strength Index (RSI) 50.59 51.97
Support Level $0.34 $0.49
Resistance Level $5.08 $0.82
Average True Range (ATR) 0.36 0.10
MACD -0.12 0.04
Stochastic Oscillator 24.88 39.59

Price Performance

Historical Comparison
IXHL
ZTEK

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About ZTEK Zentek Ltd.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Share on Social Networks: